Published in Neuroscience on November 14, 2012
Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma. J Neuroinflammation (2015) 1.49
Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation. J Neurosci (2014) 0.95
Astrocyte Reactivity: A Biomarker for Retinal Ganglion Cell Health in Retinal Neurodegeneration. J Clin Cell Immunol (2014) 0.94
Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration. Transl Vis Sci Technol (2014) 0.93
Age-related changes in the visual pathways: blame it on the axon. Invest Ophthalmol Vis Sci (2013) 0.92
Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy. Neurobiol Dis (2013) 0.88
Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma. Exp Eye Res (2015) 0.80
Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma. Mol Ther (2015) 0.80
The morphological difference between glaucoma and other optic neuropathies. J Neuroophthalmol (2015) 0.80
Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress. Channels (Austin) (2015) 0.78
Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB. PLoS One (2015) 0.77
Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss. Front Neurosci (2017) 0.76
The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications. Prog Retin Eye Res (2017) 0.76
Loss of optineurin in vivo results in elevated cell death and alters axonal trafficking dynamics. PLoS One (2014) 0.76
Molecular imaging of retinal disease. J Ocul Pharmacol Ther (2013) 0.76
Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma. Front Neurosci (2016) 0.76
Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Invest Ophthalmol Vis Sci (2015) 0.76
Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma. J Comp Neurol (2016) 0.75
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma. Front Neurosci (2017) 0.75
Retina-on-a-chip: a microfluidic platform for point access signaling studies. Biomed Microdevices (2015) 0.75
Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma. Front Neurosci (2016) 0.75
Macroglia-derived thrombospondin 2 regulates alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure. PLoS One (2017) 0.75
Role of BDNF/TrkB pathway in the visual system: Therapeutic implications for glaucoma. Expert Rev Ophthalmol (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol (2006) 25.47
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38
Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol (1983) 7.55
Primary open-angle glaucoma. N Engl J Med (2009) 4.89
Neuronal death in glaucoma. Prog Retin Eye Res (1999) 3.46
Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol (2005) 2.98
Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol (2009) 2.93
Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci (2008) 2.87
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci (2006) 2.68
Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosci (2008) 2.38
Neuronal release of proBDNF. Nat Neurosci (2009) 2.36
Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci (2000) 2.18
Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol (2007) 2.17
Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci (1998) 2.17
Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci (2000) 2.14
Neurotrophin secretion: current facts and future prospects. Prog Neurobiol (2003) 2.12
The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci (2009) 2.10
Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A (2010) 1.96
Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci (2003) 1.87
BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. J Cell Biol (2012) 1.65
Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci (2006) 1.65
Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A (1998) 1.60
Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis (2000) 1.59
Biochemical characterization and localization of a non-N-methyl-D-aspartate glutamate receptor in rat brain. J Neurochem (1992) 1.58
TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest Ophthalmol Vis Sci (2008) 1.54
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis. J Neurosci (2004) 1.51
Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet (2007) 1.48
Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons. Neuroreport (2002) 1.46
Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol (2004) 1.44
Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem (2005) 1.43
Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res (2012) 1.40
Cortical sensory map rearrangement after spinal cord injury: fMRI responses linked to Nogo signalling. Brain (2007) 1.38
Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans (2007) 1.36
Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma (1996) 1.35
BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur J Neurosci (1995) 1.31
Depth segregation of retinal ganglion cells projecting to mouse superior colliculus. J Comp Neurol (1985) 1.30
Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience (2010) 1.29
Apoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma. Exp Eye Res (2006) 1.29
The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol (2011) 1.29
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain (2008) 1.26
Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes. J Cell Biol (2008) 1.24
Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett (2001) 1.21
Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension. Brain Res (2009) 1.20
Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vision Res (2002) 1.17
Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res (2009) 1.16
Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog Brain Res (2008) 1.15
Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev (2012) 1.12
The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci (2000) 1.09
Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury. Invest Ophthalmol Vis Sci (2009) 1.07
Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain. Brain Res (1999) 1.07
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener (2011) 1.05
Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomes. J Biol Chem (1997) 1.02
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol Neurodegener (2011) 1.01
Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J Neurosci Res (2002) 0.99
Distinct subsets of Syt-IV/BDNF vesicles are sorted to axons versus dendrites and recruited to synapses by activity. J Neurosci (2012) 0.95
Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats. Brain Res (2004) 0.95
Truncated TrkB mediates the endocytosis and release of BDNF and neurotrophin-4/5 by rat astrocytes and schwann cells in vitro. Brain Res (2000) 0.94
Peripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injury. PLoS One (2008) 0.93
Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model. Exp Eye Res (2008) 0.90
High-resolution localization of clathrin assembly protein AP180 in the presynaptic terminals of mammalian neurons. J Comp Neurol (2002) 0.89
Topography of neuron loss in the retinal ganglion cell layer in human glaucoma. Br J Ophthalmol (2009) 0.89
The neuropil in superficial layers of the superior colliculus of the mouse. A correlated Golgi and electron microscopic study. Z Anat Entwicklungsgesch (1973) 0.88
Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neurol Sci (2009) 0.86
Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration. J Neurosci Res (2006) 0.84
Differential expression of the truncated TrkB receptor, T1, in the primary motor and prefrontal cortices of the adult macaque monkey. Neurosci Lett (2005) 0.84
Morphological identification of ganglion cells expressing the alpha subunit of type II calmodulin-dependent protein kinase in the macaque retina. J Comp Neurol (2005) 0.82
Expression and sequences of genes encoding glutamate receptors and transporters in primate retina determined using 3'-end amplification polymerase chain reaction. Mol Vis (2006) 0.79
Unpredictability of glaucoma progression. Curr Med Res Opin (2009) 0.78
Involvement of brain-derived neurotrophic factor in time-dependent neurodegeneration in the murine superior colliculus after intravitreal injection of N-methyl-D-aspartate. Mol Vis (2009) 0.77
Astroglial responses against Abeta initially occur in cerebral primary cortical cultures: species differences between rat and cynomolgus monkey. Neurosci Res (2004) 0.77
Reactive changes in the adult rat superior colliculus after deafferentation. Restor Neurol Neurosci (1995) 0.76
The distribution of astrocytes, oligodendroglia and myelin in normal and transplanted rat superior colliculus: an immunohistochemical study. J Neural Transplant Plast (1994) 0.76
Structural characteristics of alpha-helical peptide molecules containing Aib residues. Biochemistry (1990) 2.16
Parallel packing of alpha-helices in crystals of the zervamicin IIA analog Boc-Trp-Ile-Ala-Aib-Ile-Val-Aib-Leu-Aib-Pro-OMe.2H2O. Proc Natl Acad Sci U S A (1986) 2.10
Stereochemical modeling of disulfide bridges. Criteria for introduction into proteins by site-directed mutagenesis. Protein Eng (1989) 1.98
Design of folded peptides. Chem Rev (2001) 1.94
Conformations of disulfide bridges in proteins. Int J Pept Protein Res (1990) 1.90
The stereochemistry of peptides containing alpha-aminoisobutyric acid. CRC Crit Rev Biochem (1984) 1.63
Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer. Cancer (1992) 1.53
Crystal structure of [Leu1]zervamicin, a membrane ion-channel peptide: implications for gating mechanisms. Proc Natl Acad Sci U S A (1991) 1.35
A designed beta-hairpin peptide in crystals. Proc Natl Acad Sci U S A (1996) 1.31
Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience (2010) 1.29
Conformations of synthetic alamethicin fragments. Evidence for 310 helical folding from 270-MHz hydrogen-1 nuclear magnetic resonance and circular dichroism studies. Biochemistry (1981) 1.27
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Beta-hairpins in proteins revisited: lessons for de novo design. Protein Eng (1997) 1.22
Stereochemical control of peptide folding. Bioorg Med Chem (1999) 1.22
A designed beta-hairpin peptide. Biochem Biophys Res Commun (1995) 1.21
Alamethicin and related membrane channel forming polypeptides. Mol Cell Biochem (1983) 1.18
Stereochemical punctuation marks in protein structures: glycine and proline containing helix stop signals. J Mol Biol (1998) 1.17
Membrane channel forming polypeptides. Molecular conformation and mitochondrial uncoupling activity of antiamoebin, an alpha-aminoisobutyric acid containing peptide. Biochemistry (1986) 1.16
A model for the interaction of trifluoroethanol with peptides and proteins. Int J Pept Protein Res (1996) 1.13
De novo protein design: crystallographic characterization of a synthetic peptide containing independent helical and hairpin domains. Proc Natl Acad Sci U S A (2000) 1.12
Effects of organic solvents on protein structures: observation of a structured helical core in hen egg-white lysozyme in aqueous dimethylsulfoxide. Proteins (1997) 1.06
Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure (1997) 1.05
Thermal stabilization of thymidylate synthase by engineering two disulfide bridges across the dimer interface. J Mol Biol (1994) 1.05
Disallowed Ramachandran conformations of amino acid residues in protein structures. J Mol Biol (1996) 1.03
Conformational interconversions in peptide beta-turns: analysis of turns in proteins and computational estimates of barriers. J Mol Biol (1998) 1.01
Conformation of a 16-residue zervamicin IIA analog peptide containing three different structural features: 3(10)-helix, alpha-helix, and beta-bend ribbon. Proc Natl Acad Sci U S A (1987) 1.00
Monoclinic polymorph of Boc-Trp-Ile-Ala-Aib-Ile-Val-Aib-Leu-Aib-Pro-OMe(anhydrous). Parallel packing of 3(10)-/alpha-helices and a transition of helix type. Int J Pept Protein Res (1988) 1.00
Negative nuclear Overhauser effects as probes of macromolecular structure. J Am Chem Soc (1972) 1.00
Designed beta-hairpin peptides with defined tight turn stereochemistry. Biopolymers (2001) 1.00
Interaction of melittin with endotoxic lipid A. Biochim Biophys Acta (1992) 1.00
Peptide hybrids containing alpha - and beta-amino acids: structure of a decapeptide beta-hairpin with two facing beta-phenylalanine residues. Proc Natl Acad Sci U S A (2001) 0.99
Parallel zippers formed by alpha-helical peptide columns in crystals of Boc-Aib-Glu(OBzl)-Leu-Aib-Ala-Leu-Aib-Ala-Lys(Z)-Aib-OMe. Proc Natl Acad Sci U S A (1990) 0.99
Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer (1996) 0.97
Alpha-helix and mixed 3(10)/alpha-helix in cocrystallized conformers of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe. Proc Natl Acad Sci U S A (1989) 0.97
Conformation of the flexible bent helix of Leu1-zervamicin in crystal C and a possible gating action for ion passage. Biopolymers (1994) 0.97
Oral cancer in Southern India: the influence of body size, diet, infections and sexual practices. Eur J Cancer Prev (2003) 0.96
Helix aggregation in peptide crystals: occurrence of either all parallel or antiparallel packing motifs for alpha-helices in polymorphs of Boc-Aib-Ala-Leu-Ala-Leu-Aib-Leu-Ala-Leu-Aib-OMe. Biopolymers (1990) 0.96
Synthetic interface peptides as inactivators of multimeric enzymes: inhibitory and conformational properties of three fragments from Lactobacillus casei thymidylate synthase. Biochemistry (1998) 0.94
Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol (1997) 0.93
Isolation, purification and characterization of an antifungal molecule produced by Bacillus licheniformis BC98, and its effect on phytopathogen Magnaporthe grisea. J Appl Microbiol (2007) 0.93
Interaction of cationic amphiphilic drugs with lipid A: implications for development of endotoxin antagonists. Biochim Biophys Acta (1994) 0.93
Circular dichroism studies of helical oligopeptides. Can 3(10) and alpha-helical conformations be chiroptically distinguished? Int J Pept Protein Res (1983) 0.92
A C-H triplebond O hydrogen bond stabilized polypeptide chain reversal motif at the C terminus of helices in proteins. J Mol Biol (2002) 0.92
Nuclear magnetic resonance studies of the interaction of peptides and hormones with bovine neurophysin. Biochemistry (1973) 0.92
Aqueous channels within apolar peptide aggregates: solvated helix of the alpha-aminoisobutyric acid (Aib)-containing peptide Boc-(Aib-Ala-Leu)3-Aib-OMe.2H2O.CH3OH in crystals. Proc Natl Acad Sci U S A (1988) 0.92
Peptide models for beta-turns. A circular dichroism study. Int J Pept Protein Res (1984) 0.92
Termination of right handed helices in proteins by residues in left handed helical conformations. FEBS Lett (1993) 0.91
Conformational properties of hybrid peptides containing alpha- and omega-amino acids. J Pept Res (2004) 0.91
Neuronal chemistry and functional organization in the primate visual system. Trends Neurosci (1998) 0.91
Apolar peptide models for conformational heterogeneity, hydration, and packing of polypeptide helices: crystal structure of hepta- and octapeptides containing alpha-aminoisobutyric acid. Proteins (1990) 0.90
Hydrophobic channels in crystals of an alpha-aminoisobutyric acid pentapeptide. Biochem Biophys Res Commun (1981) 0.89
Conformational characteristics of asparaginyl residues in proteins. Int J Pept Protein Res (1994) 0.89
Cadherins as predictive markers of nodal metastasis in breast cancer. Mod Pathol (2001) 0.88
Analysis of the binding of polymyxin B to endotoxic lipid A and core glycolipid using a fluorescent displacement probe. Biochim Biophys Acta (1992) 0.88
Infrared studies on the conformation of synthetic alamethicin fragments and model peptides containing alpha-aminoisobutyric acid. Biochemistry (1980) 0.88
Crystal structure of the channel-forming polypeptide antiamoebin in a membrane-mimetic environment. Proc Natl Acad Sci U S A (1998) 0.87
Facile transition between 3(10)- and alpha-helix: structures of 8-, 9-, and 10-residue peptides containing the -(Leu-Aib-Ala)2-Phe-Aib- fragment. Protein Sci (1994) 0.87
Unfolding of an alpha-helix in peptide crystals by solvation: conformational fragility in a heptapeptide. Biopolymers (1993) 0.87
Structure of triosephosphate isomerase (TIM) from Methanocaldococcus jannaschii. Acta Crystallogr D Biol Crystallogr (2007) 0.87
Covalent reinforcement of a fragile region in the dimeric enzyme thymidylate synthase stabilizes the protein against chaotrope-induced unfolding. Biochemistry (1996) 0.86
Aromatic interactions in tryptophan-containing peptides: crystal structures of model tryptophan peptides and phenylalanine analogs. J Pept Res (2005) 0.86
Identification and characterization of a library of microheterogeneous cyclohexadepsipeptides from the fungus Isaria. J Nat Prod (2007) 0.85
Parallel and antiparallel aggregation of alpha-helices. Crystal structures of two apolar decapeptides X-Trp-Ile-Ala-Aib-Ile-Val-Aib-Leu-Aib-Pro-OMe (X = Boc, Ac). Int J Pept Protein Res (1990) 0.85
Expanding the polypeptide backbone: hydrogen-bonded conformations in hybrid polypeptides containing the higher homologues of alpha-amino acids. J R Soc Interface (2007) 0.85
Localization of kainate receptors to the presynaptic active zone of the rod photoreceptor in primate retina. Vis Neurosci (2002) 0.85
Recent results of oral cancer research in Kerala, India. Head Neck (1992) 0.85
Modular design of synthetic protein mimics. Characterization of the helical conformation of a 13-residue peptide in crystals. Biochemistry (1989) 0.85
Membrane channel forming polypeptides. 270-MHz proton magnetic resonance studies of the aggregation of the 11-21 fragment of suzukacillin in organic solvents. Biochemistry (1981) 0.84
Alpha,beta hybrid peptides: a polypeptide helix with a central segment containing two consecutive beta-amino acid residues. Proc Natl Acad Sci U S A (2004) 0.84
Adrenal carcinoma with reactive plasmacytosis. J Assoc Physicians India (1989) 0.84
Ion channel formation by zervamicin-IIB. A molecular modelling study. Eur Biophys J (1993) 0.84
Comparison of helix-stabilizing effects of alpha,alpha-dialkyl glycines with linear and cycloalkyl side chains. Biopolymers (2000) 0.83
Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms: characterization of catalytic loop open and closed conformations in the ligand-bound state. Biochemistry (2002) 0.83
Molecular carpentry: piecing together helices and hairpins in designed peptides. Chemistry (2001) 0.83
Unfolding of Plasmodium falciparum triosephosphate isomerase in urea and guanidinium chloride: evidence for a novel disulfide exchange reaction in a covalently cross-linked mutant. Biochemistry (1999) 0.83
The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides. J Endotoxin Res (2000) 0.83
Helix packing of leucine-rich peptides: a parallel leucine ladder in the structure of Boc-Aib-Leu-Aib-Aib-Leu-Leu-Leu-Aib-Leu-Aib-OMe. Proteins (1992) 0.83
Radiation-induced changes in oral carcinoma cells - a multiparametric evaluation. Cytopathology (2003) 0.83
Asparagine and glutamine differ in their propensities to form specific side chain-backbone hydrogen bonded motifs in proteins. Proteins (2012) 0.83
Peptide mimics for structural features in proteins. Crystal structures of three heptapeptide helices with a C-terminal 6-->1 hydrogen bond. Int J Pept Protein Res (1993) 0.83
An incipient 3(10) helix in Piv-Pro-Pro-Ala-NHMe as a model for peptide folding. Nature (1979) 0.83
Alterations in expression of basement membrane proteins during tumour progression in oral mucosa. Histopathology (1994) 0.83
A nuclear magnetic resonance study of the interaction of serotonin with gangliosides. FEBS Lett (1976) 0.83
Fluorescence polarization as a tool to study lectin-sugar interaction. An investigation of the binding of 4-methylumbelliferyl beta-D-galactopyranoside to Abrus precatorious agglutinin. Eur J Biochem (1981) 0.82
Cavity-creating mutation at the dimer interface of Plasmodium falciparum triosephosphate isomerase: restoration of stability by disulfide cross-linking of subunits. Biochemistry (1999) 0.82
Disulfide engineering at the dimer interface of Lactobacillus casei thymidylate synthase: crystal structure of the T155C/E188C/C244T mutant. Protein Sci (1999) 0.82
Metabolic enzymes as potential drug targets in Plasmodium falciparum. Indian J Med Res (1997) 0.82
Sparsely populated residue conformations in protein structures: revisiting "experimental" Ramachandran maps. Proteins (2013) 0.82
Zervamicins, a structurally characterised peptide model for membrane ion channels. Biochem Biophys Res Commun (1992) 0.82
Covalent tethering of the dimer interface annuls aggregation in thymidylate synthase. Protein Sci (1996) 0.82
Tryptophan-containing peptide helices: interactions involving the indole side chain. J Pept Res (2005) 0.81
Synthetic peptides as inactivators of multimeric enzymes: inhibition of Plasmodium falciparum triosephosphate isomerase by interface peptides. FEBS Lett (2001) 0.81
Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. Chem Biol (2001) 0.81
A highly active chemotactic peptide analog incorporating the unusual residue 1-aminocyclohexanecarboxylic acid at position 2. Biochem Biophys Res Commun (1985) 0.81
"Teflon-coated peptides": hexafluoroacetone trihydrate as a structure stabilizer for peptides. Biopolymers (1997) 0.81
Omega amino acids in peptide design: incorporation into helices. Biopolymers (1996) 0.81
Synthetic protein design: construction of a four-stranded beta-sheet structure and evaluation of its integrity in methanol-water systems. J Pept Res (2000) 0.81
Hexafluoroacetone hydrate as a structure modifier in proteins: characterization of a molten globule state of hen egg-white lysozyme. Protein Sci (1997) 0.81
Subunit interface mutation disrupting an aromatic cluster in Plasmodium falciparum triosephosphate isomerase: effect on dimer stability. Protein Eng (2002) 0.81
Mammalian brain plasma membranes. Isolation, enzymatic, and chemical characterization. Exp Cell Res (1976) 0.80